Objective: To analyse mitochondrial hypervariable segment I (HVS-I) variations in Pakistani type 2 diabetic subjects. Study Design: Case-control study. Place and Duration of the Study: National Institute of Diabetes and Endocrinology, Dow University of Health Sciences, Karachi, Pakistan, between January 2019 to January 2021. Methodology: DNA from whole blood was isolated, and mitochondrial HVS-I region (16024-16370) of 92 individuals, including 47 controls and 45 diabetics, was ampli ed, sequenced, and analysed. Results: Ninety-two variable sites in the sequenced region were identi ed and individuals were classi ed into 56 di erent haplotypes according to phylotree 17.0 classi cations, where major haplotype M5 was nearly 2-fold higher in diabetes. Fischer s exact test revealed variant 16189T>C signi cantly associated with diabetes (Odds ratio = 12.9, 95% CI = 0.6917 2400248) as compared to controls. The authors further analysed 1000 Genomes Project data of Pakistani Control subjects (i.e. PJL, n=96) and found that besides 16189T>C (Odds ratio = 5.875, 95% CI = 1.093 31.57, p<0.0339), 16264C>T (Odds ratio = 16, 95% CI = 0.8026 314.7, p <0.0310) also showed signi cant association with diabetic subjects. Comparing diabetic subject data with global control population data of the 1000 Genomes Project, signi cant associations of eight variants in the studied region were found. Conclusion: Based on the results of this case-control study, it can be concluded that speci c variations in the mitochondrial hypervariable segment I (HVS-I) region are signi cantly associated with type 2 diabetes in the Pakistani population. The major haplotype M5 was found to be higher in diabetic subjects and variants 16189T>C and 16264C>T were signi cantly associated with diabetes. These ndings suggest that mitochondrial DNA variations may play a role in the development of type 2 diabetes in the Pakistani population.